Sign In

Julie Norville

Building a new startup

Julie Norville is a notable entrepreneur and co-founder of Jura Bio, a startup focused on developing innovative therapies for autoimmune diseases using synthetic biology. She previously worked as a postdoctoral researcher in George Church's lab at Harvard University, where she was inspired to create solutions for real-world medical challenges, particularly after witnessing a friend's struggle with organ transplant issues and the associated immune suppression treatments.12

Professional Background

  • Education: Julie holds a PhD and has collaborated closely with other prominent scientists in the field of synthetic biology.
  • Startup Focus: Jura Bio aims to engineer chimeric antigen receptor (CAR) T cells to address autoimmune conditions rather than cancer, which is a significant shift in the application of CAR-T technology. The company is currently engaged in advancing its drug candidates against diseases like primary progressive multiple sclerosis and systemic lupus erythematosus.23
  • Current Status: As of now, Jura Bio is in the process of raising funds to support its ongoing research and development efforts.1

Norville's entrepreneurial journey reflects a broader trend among scientists transitioning from academia to industry, particularly in the biotech sector, where innovative solutions to pressing health issues are increasingly sought after.

Related Questions

What inspired Julie Norville to start Jura Bio?
How did George Church's lab influence Julie Norville's entrepreneurial journey?
What is the main focus of Jura Bio's current projects?
How does the "decoy" technology work in treating autoimmune conditions?
What challenges has Julie Norville faced while building Jura Bio?
Julie Norville
Julie Norville, photo 1
Julie Norville, photo 2
Add to my network

Location

Greater Boston